Laws banning children from working are often counterproductive. A better approach is to give parents incentives to send their kids to school
Tablets remain a problem in a record-breaking quarter
From Michael Dunn's trial in Florida to discord over open-carry laws in Colorado, the debate about gun control has driven Americans to indulge their worst behavior
The company misses earnings forecasts, drops its 2015 profit goal, and regroups
Chinese millionaires are moving in—and building up—in Arcadia, Calif.
A new book surveys the best places to hide out from the digital world
The two tech giants fight over market share and patents but not over the NBA superstar
More business schools than ever are accepting the GRE as an alternative to the GMAT, according to just-released data
Small businesses are changing hands at the fastest pace since the recession
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."